Successors to acyclovir.
Easterbrook
P
P
Department of Infection and Tropical Medicine, Birmingham Heartlands Hospital, UK.
Wood
M J
MJ
D015075:2-Aminopurine / Q000031:analogs & derivatives / Q000627:therapeutic use; D000212:Acyclovir / Q000031:analogs & derivatives / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000627:therapeutic use*; D001086:Arabinofuranosyluracil / Q000031:analogs & derivatives / Q000627:therapeutic use; D002644:Chickenpox / Q000188:drug therapy; D004352:Drug Resistance, Microbial; D000077595:Famciclovir; D006561:Herpes Simplex / Q000188:drug therapy; D006562:Herpes Zoster / Q000188:drug therapy; D006801:Humans; D000077483:Valacyclovir; D014633:Valine / Q000031:analogs & derivatives / Q000627:therapeutic use
D000998:Antiviral Agents; D001086:Arabinofuranosyluracil; D015075:2-Aminopurine; C031368:sorivudine; C067854:5-propynylarabinofuranosyluracil; D014633:Valine; D000077483:Valacyclovir; D000077595:Famciclovir; D000212:Acyclovir